Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Honglian Gui"'
Autor:
Honglian Gui, Zhenglan Zhang, Bin Chen, Yaoxing Chen, Yue Wang, Zhuo Long, Chuanwu Zhu, Yinling Wang, Zhujun Cao, Qing Xie
Publikováno v:
Infectious Diseases of Poverty, Vol 12, Iss 1, Pp 1-11 (2023)
Abstract Background With the variability in emerging data, guidance on the isolation duration for patients with coronavirus disease 2019 (COVID-19) due to the Omicron variant is controversial. This study aimed to determine the predictors of prolonged
Externí odkaz:
https://doaj.org/article/0442ee0dde8449279ca69240fd0a7b55
Autor:
Jingyuan Sun, Pei Li, Honglian Gui, Laure Rittié, David B. Lombard, Katrin Rietscher, Thomas M. Magin, Qing Xie, Li Liu, M. Bishr Omary
Publikováno v:
JCI Insight, Vol 8, Iss 14 (2023)
Keratin (K) and other intermediate filament (IF) protein mutations at conserved arginines disrupt keratin filaments into aggregates and cause human epidermolysis bullosa simplex (EBS; K14-R125C) or predispose to mouse liver injury (K18-R90C). The cha
Externí odkaz:
https://doaj.org/article/6e147275c606494284720d71e3764a41
Autor:
Zhujun Cao, Chenxi Zhang, Shuang Zhao, Zike Sheng, Xiaogang Xiang, Ruokun Li, Zhuping Qian, Yinling Wang, Bin Chen, Ziqiang Li, Yuhan Liu, Baoyan An, Huijuan Zhou, Wei Cai, Hui Wang, Honglian Gui, Haiguang Xin, Qing Xie
Publikováno v:
Infectious Diseases of Poverty, Vol 11, Iss 1, Pp 1-9 (2022)
Abstract Background Safety data reported from the large-scale clinical trials of the coronavirus disease 2019 (COVID-19) vaccine are extremely limited in patients with decompensated cirrhosis. The vaccination campaign in this specific population coul
Externí odkaz:
https://doaj.org/article/aa5ff4dcdc8c43c0b977ab50ee3141e0
Autor:
Yan Huang, Lichang Chen, Rui Huang, Chuanwu Zhu, Jia Shang, Yunsong Qian, Jianqi Lian, Longgen Liu, Jianning Jiang, Chenghai Liu, Honglian Gui, Qing Xie
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background: Both tenofovir disoproxil fumarate (TDF) and entecavir (ETV) are known to reduce the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). This study aimed to compare the difference in HCC risk reduction betwe
Externí odkaz:
https://doaj.org/article/822ce0af3f58419b967b3fc6af990475
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background and Aim: A prediction model of hepatocellular carcinoma (HCC) risk in patients with chronic liver diseases, based on age, male sex, albumin-bilirubin, and platelets (aMAP), has been previously reported. We validated the aMAP score and comp
Externí odkaz:
https://doaj.org/article/8e633822018f4230b20db2c6a2d124ac
Publikováno v:
Aging. 14:7906-7925
Autor:
Zhujun Cao, Weiyi Gao, Hong Bao, Haiyan Feng, Shuya Mei, Peizhan Chen, Yueqiu Gao, Zhilei Cui, Qin Zhang, Xianmin Meng, Honglian Gui, Weijing Wang, Yimei Jiang, Zijia Song, Yiqing Shi, Jing Sun, Yifei Zhang, Qing Xie, Yiping Xu, Guang Ning, Yuan Gao, Ren Zhao
Publikováno v:
The New England journal of medicine.
Nirmatrelvir-ritonavir has been authorized for emergency use by many countries for the treatment of coronavirus disease 2019 (Covid-19). However, the supply falls short of the global demand, which creates a need for more options. VV116 is an oral ant
Publikováno v:
Hepatology. 75:757-759
We read with interest in the autoimmune hepatitis (AIH) case following COVID-19 vaccination (1) and Dr. Mungmunpuntipantip' comment (2). COVID-19 vaccine could also act as a trigger in the disease course of AIH. We report a case of AIH exacerbation f
Publikováno v:
Immunologic Research
The association between hepatitis E virus (HEV) and autoimmune liver diseases has been well-researched; however, the focus has been on autoimmune hepatitis (AIH) and not primary biliary cholangitis (PBC). Therefore, we aimed to investigate the preval
Autor:
Zike Sheng, Wei Cai, Ziqiang Li, Jie Lu, Huijuan Zhou, Honglian Gui, Hui Wang, Qing Li, Rongtao Lai, Qing Guo, Jiayuan Jiang, Peiyun Wang, Qing Xie
Publikováno v:
Virol Sin
The study aimed to describe the epidemiological, virological and clinical features of sporadic HEV infection in eastern China. A total of 6112 patient sera were tested for anti-HEV IgG or anti-HEV IgM during one consecutive year (between August 2018